Press Release: Spiriva HandiHaler : New Analyses: Adding SPIRIVA® RESPIMAT® Effective for Uncontrolled Asthma - Regardless of Allergy Subtype

RIDGEFIELD, Conn. and LOS ANGELES, March 7, 2016 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced the presentation of new post-hoc analyses that show the addition of SPIRIVA® RESPIMAT® to other asthma maintenance therapies helps improve lung...